AzTrials
AzTrials

HealthyNCT02809482

White Adipose Tissue Clocks and High Calorie Feeding

A study testing Eucaloric feeding and Overfeeding in people with Healthy, run by University of Colorado, Denver at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Peripheral tissues (e.g. liver, adipose, muscle) express self-sustained circadian clocks that coordinate daily metabolic rhythms. The timing of clock rhythms in peripheral tissues is highly sensitive to feeding-fasting signals across the sleep-wake transition. Read more about this study

Who is it for?
Ages 20 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Eucaloric feeding and Overfeeding
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteUnited States
Study dates
Jul 2016to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • males and females aged 20-35 yr;
  • BMI 25-35 kg/m2 and weight stable (±2kg in past 2mo);
  • non-smoker;
  • sedentary to moderately active (≤3 days of exercise per week ≤30 min of exercise per session);
  • sleeping pattern of >7 hours to 9.25 hrs of sleep/night.
  • subjects will be asked to identify themselves as regular consumers of 3 balanced meals per day by answering the question: "Do you eat breakfast, lunch, and dinner on ≥ 5 days per week?"

Who cannot join

  • Smoker (current or within the previous 3 months);
  • Use any medication that could affect lipid metabolism, insulin signaling, or sleep;
  • Pregnant women will not be enrolled in the study;
  • Have a job that involves shift work;
  • Dwelling below Denver altitude (1,600 m) a year prior to testing;
  • Travel across more than one time zone 3 wk before a study;
Show all 16Show fewer
  • chronic health conditions such as diabetes, hyper or hypothyroidism, renal or liver disease, anemia, or cancer;
  • Regularly go to sleep after midnight;
  • o Subjects will be excluded if they are identified as having night eating syndrome (at least 25% of food intake is consumed after the evening meal and/or at least two episodes of nocturnal eating per week);
  • Allergy to lidocaine or similar compound;
  • Have one or more of the following out-of-range values measured on a fasting blood sample:
  • glucose > 110 mg/dl,
  • thyroid stimulating hormone <0.5 or >5.0 µU/ml.
  • Subjects who may be:
  • anemic (hemoglobin < 14.5 g/dl men, <12.3 g/dl women ),
  • have abnormal liver function tests (alanine amino transferase > 47 U/l, aspartate aminotransferase, > 47 U/l, alkaline phosphatase <39 or >117 U/l) or creatinine (>1.1 mg/dl).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Study site

    Denver, Colorado, 80045

Other trials in United States

About this study

Official title: Pilot Study to Examine the Impact of Overfeeding on Peripheral Clock Gene Expression in Humans

Peripheral tissues (e.g. liver, adipose, muscle) express self-sustained circadian clocks that coordinate daily metabolic rhythms. The timing of clock rhythms in peripheral tissues is highly sensitive to feeding-fasting signals across the sleep-wake transition. Nutritional insults such as high fat overfeeding (HF-OF) have been shown to attenuate clock gene expression in peripheral tissues resulting in a deleterious re-programming of the circadian metabolome. Studies in humans have only superficially investigated how the circadian clock machinery is impacted by nutritional signals. The overall goal of this pilot project is to take the first steps toward developing translational methods to investigate links between changes in energy flux and the circadian system in human tissues. Using an innovative ex vivo cell culture approach the investigators will examine the impact of 3-days of HF-OF compared to eucaloric (EU) feeding on the expression of core clock genes in human subcutaneous adipose tissue (SAT). The Investigators hypothesize that compared to EU, the amplitude of clock gene expression in SAT measured over 24hrs will be attenuated following short-term HF-OF. This pilot project will serve as a launch point for designing future studies into the effects of diet and exercise on the circadian control of metabolism in adipose tissue depots as well as other tissues (e.g. muscle).

Conditions
Healthy
Being tested
Eucaloric feeding, Overfeeding
Keywords
Volunteers

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Eucaloric feedingOther

    3 days of a diet designed to maintain energy balance

  • OverfeedingOther

    3 days of a diet designed to induce a 40% positive energy balance

Study groups in NCT02809482
Study groupRoleWhat they receive
Eucaloric FeedingOtherNot described
Receives: Other: Eucaloric feeding
OverfeedingOtherNot described
Receives: Other: Overfeeding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Expression of clock genes in adipose tissue.

    Gene expression measured at two time points from abdominal fat.

    Measured: Measured through study completion, an average of 4 weeks.

Secondary outcomes (2)
  1. Gene expression of key cellular fuel sensors thought to be controlled. and/or influenced by peripheral clocks

    Gene expression measured at two time points from abdominal fat.

    Measured: Measured through study completion, an average of 4 weeks.

  2. Expression of clock genes in blood monocytes.

    Gene expression measured at two time points from abdominal fat.

    Measured: Measured through study completion, an average of 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionSep 2017
  4. Study completionSep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02809482
Sponsor's protocol ID
15-1570
Other IDs
UL1TR001082
Status last verified
Jun 2019
First submitted
7 Dec 2015
Last updated
1 Jul 2019
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, Buhr ED, Siepka SM, Hong HK, Oh WJ, Yoo OJ, Menaker M, Takahashi JS. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46. doi: 10.1073/pnas.0308709101. Epub 2004 Feb 12.

    PubMed 14963227
  • Oosterman JE, Kalsbeek A, la Fleur SE, Belsham DD. Impact of nutrients on circadian rhythmicity. Am J Physiol Regul Integr Comp Physiol. 2015 Mar 1;308(5):R337-50. doi: 10.1152/ajpregu.00322.2014. Epub 2014 Dec 17.

    PubMed 25519730
  • Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, Dilag-Penilla SA, Dyar KA, Baldi P, Sassone-Corsi P. Reprogramming of the circadian clock by nutritional challenge. Cell. 2013 Dec 19;155(7):1464-78. doi: 10.1016/j.cell.2013.11.034.

    PubMed 24360271
  • Pivovarova O, Jurchott K, Rudovich N, Hornemann S, Ye L, Mockel S, Murahovschi V, Kessler K, Seltmann AC, Maser-Gluth C, Mazuch J, Kruse M, Busjahn A, Kramer A, Pfeiffer AF. Changes of Dietary Fat and Carbohydrate Content Alter Central and Peripheral Clock in Humans. J Clin Endocrinol Metab. 2015 Jun;100(6):2291-302. doi: 10.1210/jc.2014-3868. Epub 2015 Mar 30.

    PubMed 25822100
  • Rynders CA, Morton SJ, Bessesen DH, Wright KP Jr, Broussard JL. Circadian Rhythm of Substrate Oxidation and Hormonal Regulators of Energy Balance. Obesity (Silver Spring). 2020 Jul;28 Suppl 1(Suppl 1):S104-S113. doi: 10.1002/oby.22816. Epub 2020 May 28.

    PubMed 32463976

Questions about this trial

What is this clinical trial studying?

A study testing Eucaloric feeding and Overfeeding in people with Healthy, run by University of Colorado, Denver at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Expression of clock genes in adipose tissue. (time frame: Measured through study completion, an average of 4 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02809482, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in